EU nears decision on Novavax COVID-19 vaccine
The European Medicines Agency (EMA) could issue an opinion on Novavax’ Conditional Marketing Authorization for its COVID-19 vaccine ‘within weeks’.
Archives for November 18, 2021
Biogen receives ‘negative trend vote’ for aducanumab in the EU
Biogen says it is disappointed with feedback received from a European Medicines Agency committee on its aducanumab Marketing Authorization Application: but pledges to continue to engage with the regulator as it considers its next steps.
Celltrion: ‘We plan to provide our treatment at a more affordable price than other monoclonal antibodies’
This last week saw the EU Commission approve two monoclonal antibodies for the treatment of COVID-19.
Increased demand for CDMO microbial outsourcing services
Biotech innovators are looking to CDMOs for their key microbial expertise in order to move their therapies from lab to the market, says Lonza.